Johnson & Johnson faces lag in Covid-19 vaccine production, NYT reports
From CNN Health's Jacqueline Howard
An investigational pharmacy technician holds a dose of the Johnson & Johnson Covid-19 vaccine before it is administered in a clinical trial in Aurora, Colorado, on December 15, 2020. Michael Ciaglo/Getty Images
The production pace of the Covid-19 vaccine being developed by drugmaker Johnson & Johnson's subsidiary Janssen appears to be behind schedule.
The New York Times reported on Wednesday that Operation Warp Speed's lead manufacturing adviser Dr. Carlo de Notaristefani acknowledged a delay, but said the company might be able to catch up with its original production goals by March. The vaccine is delivered as a one-dose shot could help ramp up vaccination efforts as the United States continues to fight a devastating pandemic.